Utility of Prognostic Markers in Second-line Treatment of Metastatic Urothelial Cancer

Clin Oncol (R Coll Radiol). 2017 Nov;29(11):e206. doi: 10.1016/j.clon.2017.07.015. Epub 2017 Aug 19.

¹ Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Division of Molecular and Clinical Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
² Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

No abstract available

Publication types